A comprehensive review of Semax (Met-Glu-His-Phe-Pro-Gly-Pro), the ACTH(4-7) analog. Covers BDNF/NGF upregulation, dopaminergic and serotonergic modulation, cerebrovascular protection, and neuroprotective mechanisms in published preclinical research.
Peptide Profiles
In-depth research profiles of individual peptides
Selank: The Russian Anti-Anxiety Peptide That Doubles as a Nootropic
A research review of Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), the synthetic tuftsin analog developed at the Russian Academy of Sciences. Covers GABAergic modulation, BDNF expression, enkephalin stabilization, and cognitive enhancement findings in preclinical models.
GHK-Cu: 30 Years of Copper Peptide Research
A comprehensive review of 50+ years of published research on GHK-Cu (glycyl-L-histidyl-L-lysine copper), covering gene expression modulation, extracellular matrix remodeling, antioxidant mechanisms, and tissue repair studies.
GLP-3R: The First Triple Receptor Agonist (And Why It Matters)
A comprehensive review of published Phase 2 and Phase 3 clinical trial data on retatrutide (LY3437943), the first triple GLP-1/GIP/glucagon receptor agonist peptide, including the TRIUMPH program and hepatic research findings.